John Leonard, MD, from Weill Cornell Medical College, New York City, NY, gives his insight into the key highlights from the American Society of Hematology (ASH) 2018 Annual Meeting and Exposition in San Diego, CA, regarding non-Hodgkin lymphoma. Prof. Leonard discusses the clinical trials looking to maximize efficacy whilst reducing toxicity, offering an improved treatment landscape for patients.